Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients

Author： Angeloni Giulia   Latteri Miriam   Manna Raffaele   Rumi Carlo   Gasbarrini Giovanni   Navarra Pierluigi  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.60, Iss.3, 2004-05, pp. : 161-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacokinetics of Cyclosporin Microemulsion in Patients with Inflammatory Bowel Disease

By Latteri M.  

Clinical Pharmacokinetics, Vol. 40, Iss. 6, 2001-01 ,pp. : 473-483

Adis International

Access to resources Recommend Favorite

Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease

By Eksteen Bertus   Miles Alice E.   Grant Allister J.   Adams David H.  

Clinical Medicine, Vol. 4, Iss. 2, 2004-03 ,pp. : 173-180

Royal College Of Physicians

Access to resources Recommend Favorite

Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease

By  

Current Drug Metabolism, Vol. 15, Iss. 9, 2014-11 ,pp. : 875-881

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients

By  

Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. : 235-247

Bentham Science Publishers

Access to resources Recommend Favorite

Inadequate sunlight exposure in patients with inflammatory bowel disease

By  

Journal of Digestive Diseases, Vol. 19, Iss. 1, 2018-01 ,pp. : 8-14

John Wiley & Sons Inc

Access to resources Recommend Favorite